Research Study

A Randomised, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Multi-centre Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function
Principal Investigator 
David M. Thompson

Overview

Body Locations and Systems 
Diabetes - Type 1
Disorders and Conditions 
Diabetes Type 1
ClinicalTrials.gov# 
NCT02443155
Status 
Recruiting
Study Start/End 
Oct 20, 2015 to Nov 27, 2018
Locations 
Vancouver General Hospital
Name/Title 
Barbara Allan, Research Coordinator
Phone 
604-875-5996
Email Address 
barbara.allan@vch.ca
Purpose of Study 

This trial is conducted globally. The aim of this trial is to assess clinical proof-of-principle of NNC0114-0006 and liraglutide on preservation of beta-cell function in adult subjects with newly diagnosed type 1 diabetes mellitus.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.